Newswise Feature Channel: Autoimmune Diseases

Antibody Targeting CD38 Enzyme Shows Positive Impact in Treating Systemic Sclerosis

Michigan Medicine - University of Michigan — Fri, 06 Sep 2024 10:05:34 EST

Scleroderma is a chronic autoimmune disease of women.Over time, people living with scleroderma develop progressive and irreversible scarring.Scarring, called fibrosis, effects the lungs, heart and kidneys, leading to poor quality of life, disability and a reduced life expectancy.

Computer model boosts detection of cell-to-cell communication

UT Southwestern Medical Center — Tue, 03 Sep 2024 10:05:43 EST

A computer model developed by UT Southwestern Medical Center researchers significantly enhances the ability of scientists to detect communication between cells, according to a new study published in Nature Methods.

Yale study reveals molecular mechanism behind multiple sclerosis

Yale School of Medicine — Fri, 30 Aug 2024 09:05:36 EST

EVOQ Therapeutics Secures $2 Million in Funding for Advanced Autoimmune NanoDisc Therapies

EVOQ Therapeutics, Inc. — Thu, 29 Aug 2024 06:05:52 EST

EVOQ Therapeutics, Inc. (EVOQ) a biopharmaceutical company dedicated to the treatment of autoimmune diseases, announced today the receipt of a $2 million grant from the National Institutes of Health (NIH) to advance novel therapies for autoimmune diseases.

Tiny Killers: How Autoantibodies Attack the Heart in Lupus Patients

Columbia University School of Engineering and Applied Science — Tue, 20 Aug 2024 15:05:37 EST

n a new study, a team of researchers from Columbia Engineering, Columbia University Vagelos College of Physicians and Surgeons, and Harvard University report that autoantibodies alone directly affect heart function in lupus patients.

MSK Research Highlights, August 13, 2024

Memorial Sloan Kettering Cancer Center — Tue, 13 Aug 2024 10:05:38 EST

New research from Memorial Sloan Kettering Cancer Center (MSK) found patients with non-small cell lung cancer brain metastases may benefit from up-front stereotactic radiosurgery; identified a connection between antibiotic use and autoimmune diseases; and uncovered a previously unknown structural role for messenger RNAs in the cytoplasm of cells.

Could targeting metabolism treat blood clots in antiphospholipid syndrome?

Michigan Medicine - University of Michigan — Tue, 13 Aug 2024 09:05:03 EST

Neutrophils are an important type of white blood cell that help your immune system fight infections. One of the many ways neutrophils help is by capturing germs in sticky, spider web-like structures called neutrophil extracellular traps, or NETs.However, excessive formation of NETs is seen in many autoimmune diseases as a sign of exuberant inflammation.

Researchers crack a key celiac mystery

McMaster University — Fri, 09 Aug 2024 11:00:00 EST

An interdisciplinary team of medical and engineering researchers has spent the last six years working to unlock a significant piece of the puzzle in the search for a cure: how and where the gluten response begins.

Thermo Fisher Scientific Showcases Diagnostics Innovation Across Therapeutic Areas at ADLM 2024

ADLM 2024 Press Program — Fri, 26 Jul 2024 10:05:25 EST

Thermo Fisher Scientific Inc. will showcase its broad diagnostics portfolio and host a series of customer-led workshops and presentations that highlight industry developments and the company's latest innovations during the Association for Diagnostics & Laboratory Medicine Conference (ADLM) July 28-Aug. 1, 2024, in Chicago, Ill.

High Levels of a Specific Antibody May Contribute to Acute Coronary Syndrome

Cedars-Sinai — Wed, 24 Jul 2024 20:05:12 EST

How a person's immune system responds to a protein called LL-37 may increase risk for developing acute coronary syndrome, but the response may also serve as a potential target for future treatments.

Microrobot-packed pill shows promise for treating inflammatory bowel disease in mice

University of California San Diego — Wed, 26 Jun 2024 14:00:00 EST

Engineers at the University of California San Diego have developed a pill that releases microscopic robots, or microrobots, into the colon to treat inflammatory bowel disease (IBD). The experimental treatment, given orally, has shown success in mice.

New research points to 'stem-like' T cells as culprits in ulcerative colitis

La Jolla Institute for Immunology — Wed, 19 Jun 2024 05:00:00 EST

The researchers hope to one day target this T cell population via drug therapy. "These cells may be a very important target for treating ulcerative colitis and perhaps other autoimmune diseases..."

UTEP Pharmacy Researchers Develop Potential Treatment for Fibrosis

University of Texas at El Paso — Thu, 06 Jun 2024 16:05:40 EST

Researchers at The University of Texas at El Paso are developing a new therapeutic approach that uses nanoparticles for the treatment of skin and lung fibrosis, conditions that can result in severe damage to the body's tissues.

Autoimmune disease not associated with monoclonal gammopathy

American College of Physicians (ACP) — Mon, 20 May 2024 17:00:00 EST

A study of more than 75,000 persons screened for monoclonal gammopathy of undetermined significance (MGUS) found no association between the presence of autoimmune diseases and MGUS.

Mayo Clinic Laboratories and Progentec Diagnostics Launch Lupus Advanced Biomarker Testing Services

Mayo Clinic — Wed, 01 May 2024 09:10:59 EST

As a successful outcome of the collaboration announced in 2023 between Mayo Clinic Laboratories, a leading global reference laboratory, and Progentec Diagnostics, a digital health and biomarker technology-based company focused on autoimmune conditions, Progentec's proprietary biomarker blood tests for the proactive management of systemic lupus erythematosus are available.

The Autoimmune Association Announces the Inaugural Young Adult Advisory Council

Autoimmune Association — Wed, 10 Apr 2024 16:05:57 EST

The Autoimmune Association The Autoimmune Association, the world's leading nonprofit organization dedicated to autoimmune advocacy, awareness, education, and research, announces the 16 individuals appointed to the newly established Young Adult Advisory Council (YAAC), dedicated to empowering and advocating for young individuals aged 15 to 25 living with autoimmune disease.

COVID-19 associated with increased risk for autoimmune inflammatory rheumatic diseases up to a year after infection

American College of Physicians (ACP) — Mon, 04 Mar 2024 17:00:00 EST

A large, binational study found that SARS-CoV-2 infection was associated with an increased risk for autoimmune inflammatory rheumatic diseases (AIRDs) that extends up to 12 months after infection. The risk was found to be higher with greater severity of acute COVID-19, even among those who were vaccinated. These findings suggest that care strategies for patients who survive COVID-19 should pay close attention to manifestations of AIRD, particularly after severe illness. The study is published in Annals of Internal Medicine.

Biochemists discover what affects the development of autoimmune diseases

Scientific Project Lomonosov — Wed, 28 Feb 2024 03:05:34 EST

The biochemist of RUDN University and Institute of Biomedical Chemistry was the first to study how variants of the protein that controls T-lymphocytes affect the development of autoimmune diseases using the example of multiple sclerosis. This will help find new approaches to the treatment of autoimmune diseases.

Researchers identify new choice of therapy for rare autoimmune disease EGPA

McMaster University — Fri, 23 Feb 2024 13:05:05 EST

An international team, including researchers from McMaster University and St. Joseph's Healthcare Hamilton, has identified a new therapeutic for patients with a rare autoimmune disease called eosinophilic granulomatosis with polyangiitis (EGPA). A biologic drug called benralizumab has been shown to be non-inferior to mepolizumab in the treatment of EGPA.

Long COVID can happen to anyone. Keep up with the latest research on Long COVID on Newswise

Newswise — Wed, 21 Feb 2024 14:05:03 EST

Stay informed! These are the latest research articles on "Long COVID" from the Coronavirus News Source on Newswise.